Clinical Trial Update: A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating use of hepatitis C-positive donors for hepatitis C-negative lung transplant recipients with post-transplant treatment with Mavyret (gle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Lung Transplant Recipients

Drugs mentioned

• Mavyret (glecaprevir/pibrentasvir)

Snippet

Sponsor: NYU Langone Health | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2021-09-05